About Index Trending news
Analyze
Top 50 Pricing
Verastem

Verastem

Work at Verastem? Add yourself to this profile

Verastem

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$20,000,000
Venture capital (Series B)
$32,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug

Xconomy

Verastem Sinks as Mesothelioma Study Halted For Futility